From: Advanced glycation end products and diabetes and other metabolic indicators
 | Normal | Impaired glucose tolerance(IGT) | DM | χ2 value |
---|---|---|---|---|
Age | ||||
 < 65 | 541(82.80%) | 63(9.60%) | 49(7.50%) | 20.11** |
 ≥ 65 | 173(71.50%) | 27(11.20%) | 42(17.40%) |  |
Gender | 5.23 | |||
 Male | 378(77.50%) | 59(12.10%) | 51(10.50%) |  |
 Female | 345(82.50%) | 32(7.70%) | 41(9.80%) |  |
BMI | 12.20** | |||
 Normal | 402(83.60%) | 41(8.50%) | 38(7.90%) |  |
 Overweight | 257(76.90%) | 39(11.70%) | 38(11.40%) |  |
 Obesity | 64(71.10%) | 10(11.10%) | 16(17.80%) |  |
HDL | ||||
 Normal | 669(80.00%) | 85(10.20%) | 82(9.80%) | 1.51 |
 Abnormal | 54(77.10%) | 6(8.60%) | 10(14.30%) |  |
UA | 2.69 | |||
 Normal | 542(80.70%) | 61(9.10%) | 69(10.30%) |  |
 Abnormal | 181(77.40%) | 30(12.80%) | 23(9.80%) |  |
TC | 2.28 | |||
 Normal | 624(80.00%) | 81(10.40%) | 75(9.60%) |  |
 Abnormal | 99(78.60%) | 10(7.90%) | 17(13.50%) |  |
TG | 6.23* | |||
 Normal | 518(82.00%) | 58(9.20%) | 56(8.90%) |  |
 Abnormal | 205(74.80%) | 33(12.00%) | 36(13.10%) |  |
SBP | 27.72** | |||
 Normal | 577(83.40%) | 64(9.20%) | 51(7.40%) |  |
 Abnormal | 143(68.40%) | 27(12.90%) | 39(18.70%) |  |
AGE | 37.95** | |||
 ≤ P25 | 193(84.60%) | 23(10.10%) | 12(5.30%) |  |
 P25–P50 | 191(84.90%) | 23(10.20%) | 11(4.90%) |  |
 P50–P75 | 177(77.60%) | 27(11.80%) | 24(10.50%) |  |
 > P75 | 162(72.00%) | 18(8.00%) | 45(20.00%) |  |